日内瓦–(BUSINESS WIRE)–(美国商业资讯)–致力于帮助人们拥有明亮双眸的全球眼科保健领导者爱尔康(Alcon)今天宣布作为一家独立上市公司亮相，并完成从诺华(Novartis)的拆分。该公司股票于今日起在瑞士证券交易所(SIX Swiss Exchange)和纽约证券交易所(NYSE)上市交易，交易代码为“ALC”。 爱尔康是全球最大的眼科保健器械公司，其手术产品和视力保健产品业务相辅相成。该公司业务覆盖全球74个国家，为140多个国家的患者服务，在新兴市场的业务快速发展。爱尔康…
Author: Business Wire
STAAR Surgical Celebrates One Million Lens Milestone for Implantable Collamer® Lens (ICL)
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer, and marketer of implantable lenses and companion delivery systems for the eye, today announced that more than one million Visian implantable…
Alcon debuta como compañía independiente que cotiza en bolsa
GINEBRA–(BUSINESS WIRE)–Alcon, el líder global en atención oftalmológica especializado en ayudar a las personas a ver con brillantez, hoy anunció su debut como una compañía independiente que cotiza en bolsa así como la conclusión de su separación de …
Alcon estreia como uma empresa independente de capital aberto
GENEBRA–(BUSINESS WIRE)–Alcon, líder global em produtos oftalmológicos dedicada a ajudar as pessoas a enxergarem melhor, anunciou hoje sua estreia como uma empresa independente, de capital aberto e a conclusão da sua separação da Novartis. As ações d…
Allegro Ophthalmics Appoints Marc Carlson and Rebecca Colbert to the Company’s Board of Directors
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DME?src=hash" target="_blank"gt;#DMElt;/agt;–Allegro Ophthalmics, LLC today announced that Marc Carlson and Rebecca Colbert have b…
Samenvatting: Alcon debuteert als onafhankelijke, beursgenoteerde onderneming
GENEVA–(BUSINESS WIRE)–Alcon, wereldleider in oogzorg die mensen op briljante wijze helpt te zien, heeft vandaag haar debuut als een onafhankelijk, beursgenoteerd bedrijf en de voltooiing van de scheiding van Novartis aangekondigd. De aandelen van he…
Riassunto: Alcon debutta come società indipendente quotata in borsa
GINEVRA–(BUSINESS WIRE)–Alcon, società leader a livello globale nel settore oftalmico dedita ad aiutare le persone a vedere al meglio, ha annunciato oggi il proprio debutto come società indipendente quotata in borsa e il completamento del processo di…
STAAR Surgical to Report First Quarter Results on May 1, 2019
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the…
Alcon debütiert als unabhängiges, börsennotiertes Unternehmen
GENF–(BUSINESS WIRE)–Alcon, das weltweit führende Unternehmen für Augenheilkunde zur Unterstützung der Menschen für ausgezeichnete Sicht, gab heute sein Debüt als unabhängiges, vollständig von Novartis abgetrenntes, börsennotiertes Unternehmen bekann…
Alcon Debuts as Independent, Publicly Traded Company
GENEVA–(BUSINESS WIRE)–Alcon Debuts as Independent, Publicly Traded Company; Company Completes Separation from Novartis
Alcon fait ses débuts en tant que société indépendante cotée en bourse
GENÈVE–(BUSINESS WIRE)–Alcon, le leader mondial des soins de la vue dont la mission est d’aider les personnes à voir le monde dans toute sa splendeur, a annoncé aujourd’hui ses débuts en tant que société indépendante cotée en bourse et l’achèvement d…
Alcon Debuts as Independent, Publicly Traded Company
GENEVA–(BUSINESS WIRE)–Alcon Debuts as Independent, Publicly Traded Company; Company Completes Separation from Novartis
Optometry Times® Editor Dr. Ben Casella Named Optometrist of the Year by AOA
CRANBURY, N.J.–(BUSINESS WIRE)–Optometry Times® Editor Dr. Ben Casella Named Optometrist of the Year by AOA
$12 Billion Contact Lenses Market – Global Outlook and Forecast 2019-2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market – Global Outlook and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The global contact lenses market is estimated to reach revenues of more than $12 billion by 2024, growing at CAGR of around 6% during 2018-2024. The advent of low-cost manufacturing techniques and the invention of new silicone hydrogel-based polymers will boost the demand for daily use, the disposable lens in the market. The leading vendors are
Aerpio Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that Chief Executive Officer, …
Guardion Health Sciences, Inc. Announces Pricing of Initial Public Offering
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24GHSI&src=ctag" target="_blank"gt;$GHSIlt;/agt; lt;a href="https://twitter.com/hashtag/IPO?src=hash" target="_b…
Global Anterior Uveitis Clinical Trials Review, H2, 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Anterior Uveitis Global Clinical Trials Review, H2, 2018″ clinical trials has been added to ResearchAndMarkets.com’s offering. Anterior Uveitis Global Clinical Trials Review, H2, 2018” provides an overview of Anterior Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Anterior Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report
Juvenile Macular Degeneration (Stargardt Disease) Pipeline Review, H1 2019 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Juvenile Macular Degeneration (Stargardt Disease) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Juvenile Macular Degeneration (Stargardt Disease) – Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of admi
Ocular Hypertension Pipeline Review, H1 2019 by Stage of Development, Drug Target, MoA, RoA and Molecule Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Hypertension – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Ocular Hypertension – Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Ocular Hypertension (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological actio
Physicians Protocol Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts
GREENSBORO, N.C.–(BUSINESS WIRE)–Karl Stonecipher, MD at Physicians Protocol, is participating in the AcuFocus clinical study for the IC-8 intraocular lens designed for cataracts.